Tony van Bijleveld
Nessuna posizione attualmente
Profilo
Tony van Bijleveld formerly worked at Nano Mobile Healthcare, Inc., as Independent Director from 2014 to 2017, UDG Healthcare Ltd.
(Dublin), as Managing Director from 2010 to 2012, Kcl Foundation Labs, as Managing Director from 1982 to 1989, Merck & Co., Inc., as President-Russian Region from 2007 to 2010, Patheon, Inc., as General Manager, N.V.
Organon, as General Manager, Schering-Plough Pharmaceuticals, as President, Organon Biosciences, Inc., as Senior Vice President, and Walgreens Boots Alliance Ltd., as General Manager-European Region.
Precedenti posizioni note di Tony van Bijleveld
Società | Posizione | Fine |
---|---|---|
NANO MOBILE HEALTHCARE, INC. | Direttore/Membro del Consiglio | 23/05/2017 |
Walgreens Boots Alliance Ltd.
Walgreens Boots Alliance Ltd. Pharmaceuticals: MajorHealth Technology Walgreens Boots Alliance Ltd. operates as an investment holding company. The company was founded on March 19, 2007 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2014 |
UDG HEALTHCARE PLC | Corporate Officer/Principal | 01/09/2012 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/02/2010 |
Kcl Foundation Labs | Amministratore Delegato | 01/01/1989 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NANO MOBILE HEALTHCARE, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
Aziende private | 7 |
---|---|
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
UDG Healthcare Ltd. (Dublin)
UDG Healthcare Ltd. (Dublin) Miscellaneous Commercial ServicesCommercial Services UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland. | Commercial Services |
Organon Biosciences, Inc. | |
Kcl Foundation Labs | |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
Walgreens Boots Alliance Ltd.
Walgreens Boots Alliance Ltd. Pharmaceuticals: MajorHealth Technology Walgreens Boots Alliance Ltd. operates as an investment holding company. The company was founded on March 19, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
Schering-Plough Pharmaceuticals |
- Borsa valori
- Insiders
- Tony van Bijleveld